- Home
- BNR vs SWIN Comparison
BNR vs SWIN Comparison
Compare BNR & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- SWIN
- Stock Information
- Founded
- BNR 2014
- SWIN 2017
- Country
- BNR China
- SWIN Hong Kong
- Employees
- BNR N/A
- SWIN N/A
- Industry
- BNR Medical Specialities
- SWIN
- Sector
- BNR Health Care
- SWIN
- Exchange
- BNR Nasdaq
- SWIN Nasdaq
- Market Cap
- BNR 29.1M
- SWIN 32.1M
- IPO Year
- BNR 2020
- SWIN 2023
- Fundamental
- Price
- BNR $3.83
- SWIN $3.98
- Analyst Decision
- BNR
- SWIN
- Analyst Count
- BNR 0
- SWIN 0
- Target Price
- BNR N/A
- SWIN N/A
- AVG Volume (30 Days)
- BNR 36.5K
- SWIN 238.6K
- Earning Date
- BNR 08-21-2025
- SWIN 08-21-2025
- Dividend Yield
- BNR N/A
- SWIN N/A
- EPS Growth
- BNR N/A
- SWIN N/A
- EPS
- BNR N/A
- SWIN N/A
- Revenue
- BNR $72,112,038.00
- SWIN $3,316,000.00
- Revenue This Year
- BNR $136.32
- SWIN $29.79
- Revenue Next Year
- BNR N/A
- SWIN $54.60
- P/E Ratio
- BNR N/A
- SWIN N/A
- Revenue Growth
- BNR 0.53
- SWIN N/A
- 52 Week Low
- BNR $2.18
- SWIN $1.16
- 52 Week High
- BNR $7.90
- SWIN $4.40
- Technical
- Relative Strength Index (RSI)
- BNR 61.98
- SWIN 87.26
- Support Level
- BNR $3.06
- SWIN $2.88
- Resistance Level
- BNR $3.50
- SWIN $4.40
- Average True Range (ATR)
- BNR 0.23
- SWIN 0.40
- MACD
- BNR 0.03
- SWIN 0.15
- Stochastic Oscillator
- BNR 84.78
- SWIN 91.70
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.